Format
Sort by
Items per page

Send to

Choose Destination

Best matches for resveratrol prostate cancer:

Search results

Items: 1 to 20 of 253

1.

Comparative Evaluation of Solubility, Cytotoxicity and Photostability Studies of Resveratrol and Oxyresveratrol Loaded Nanosponges.

Dhakar NK, Matencio A, Caldera F, Argenziano M, Cavalli R, Dianzani C, Zanetti M, López-Nicolás JM, Trotta F.

Pharmaceutics. 2019 Oct 20;11(10). pii: E545. doi: 10.3390/pharmaceutics11100545.

2.

Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy.

Chaudhary Z, Subramaniam S, Khan GM, Abeer MM, Qu Z, Janjua T, Kumeria T, Batra J, Popat A.

Front Bioeng Biotechnol. 2019 Sep 18;7:225. doi: 10.3389/fbioe.2019.00225. eCollection 2019.

3.

Chemoprevention of Prostate Cancer by Natural Agents: Evidence from Molecular and Epidemiological Studies.

Mokbel K, Wazir U, Mokbel K.

Anticancer Res. 2019 Oct;39(10):5231-5259. doi: 10.21873/anticanres.13720. Review.

PMID:
31570421
4.

Expression of Concern: Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor.

PLOS ONE Editors.

PLoS One. 2019 Sep 24;14(9):e0223138. doi: 10.1371/journal.pone.0223138. eCollection 2019. No abstract available.

5.

MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.

Kumar A, Dholakia K, Sikorska G, Martinez LA, Levenson AS.

Nutrients. 2019 Sep 4;11(9). pii: E2096. doi: 10.3390/nu11092096.

6.

Resveratrol derivatives increase cytosolic calcium by inhibiting plasma membrane ATPase and inducing calcium release from the endoplasmic reticulum in prostate cancer cells.

Peterson JA, Crowther CM, Andrus MB, Kenealey JD.

Biochem Biophys Rep. 2019 Jul 20;19:100667. doi: 10.1016/j.bbrep.2019.100667. eCollection 2019 Sep.

7.

Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.

Thipe VC, Panjtan Amiri K, Bloebaum P, Raphael Karikachery A, Khoobchandani M, Katti KK, Jurisson SS, Katti KV.

Int J Nanomedicine. 2019 Jun 18;14:4413-4428. doi: 10.2147/IJN.S204443. eCollection 2019.

8.

Anti-cancerous Effect of Rutin Against HPV-C33A Cervical Cancer Cells via G0/G1 Cell Cycle Arrest and Apoptotic Induction

Khan F, Pandey P, Upadhyay TK, Jafri A, Jha NK, Mishra R, Singh V.

Endocr Metab Immune Disord Drug Targets. 2019 Aug 6. doi: 10.2174/1871530319666190806122257. [Epub ahead of print]

PMID:
31385777
9.

Phytochemicals as Modulators of Long Non-Coding RNAs and Inhibitors of Cancer-Related Carbonic Anhydrases.

Saghafi T, Taheri RA, Parkkila S, Emameh RZ.

Int J Mol Sci. 2019 Jun 15;20(12). pii: E2939. doi: 10.3390/ijms20122939. Review.

10.

Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.

Jang YG, Go RE, Hwang KA, Choi KC.

J Steroid Biochem Mol Biol. 2019 Sep;192:105406. doi: 10.1016/j.jsbmb.2019.105406. Epub 2019 Jun 8.

PMID:
31185279
11.

Curcumin: Total-Scale Analysis of the Scientific Literature.

Yeung AWK, Horbańczuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, Marchewka J, Sut S, Dall'Acqua S, Gan RY, Tancheva LP, Polgar T, Berindan-Neagoe I, Pirgozliev V, Šmejkal K, Atanasov AG.

Molecules. 2019 Apr 9;24(7). pii: E1393. doi: 10.3390/molecules24071393.

12.

Evaluation of biophysical as well as biochemical potential of curcumin and resveratrol during prostate cancer.

Guo W, Wu X, Li Y, Gao J, Wang F, Jin Y, Chong T, Malhotra A.

J Drug Target. 2019 Nov 4:1-5. doi: 10.1080/1061186X.2019.1601199. [Epub ahead of print]

PMID:
30943812
13.

Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer.

De Amicis F, Chimento A, Montalto FI, Casaburi I, Sirianni R, Pezzi V.

Int J Mol Sci. 2019 Mar 3;20(5). pii: E1087. doi: 10.3390/ijms20051087. Review.

14.

Resveratrol integrates metabolic and growth effects in PC3 prostate cancer cells-involvement of prolyl hydroxylase and hypoxia inducible factor-1.

Fonseca J, Moradi F, Maddalena LA, Ferreira-Tollstadius B, Selim S, Stuart JA.

Oncol Lett. 2019 Jan;17(1):697-705. doi: 10.3892/ol.2018.9526. Epub 2018 Sep 28.

15.

Clustering, Pathway Enrichment, and Protein-Protein Interaction Analysis of Gene Expression in Neurodevelopmental Disorders.

Yadav R, Srivastava P.

Adv Pharmacol Sci. 2018 Nov 27;2018:3632159. doi: 10.1155/2018/3632159. eCollection 2018.

16.

Systematic review and meta-analysis of the protective effect of resveratrol on multiple organ injury induced by sepsis in animal models.

Zhou J, Yang D, Liu K, Hou L, Zhang W.

Biomed Rep. 2019 Jan;10(1):55-62. doi: 10.3892/br.2018.1169. Epub 2018 Nov 14.

17.

Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin.

Martínez-Martínez D, Soto A, Gil-Araujo B, Gallego B, Chiloeches A, Lasa M.

Food Chem Toxicol. 2019 Feb;124:273-279. doi: 10.1016/j.fct.2018.12.014. Epub 2018 Dec 12.

PMID:
30552915
18.
19.

In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer.

Kumar A, D'silva M, Dholakia K, Levenson AS.

Nutrients. 2018 Nov 20;10(11). pii: E1804. doi: 10.3390/nu10111804.

20.

Oxygen and Glucose Levels in Cell Culture Media Determine Resveratrol's Effects on Growth, Hydrogen Peroxide Production, and Mitochondrial Dynamics.

Fonseca J, Moradi F, Valente AJF, Stuart JA.

Antioxidants (Basel). 2018 Nov 5;7(11). pii: E157. doi: 10.3390/antiox7110157.

Supplemental Content

Loading ...
Support Center